Halozyme Therapeutics, Inc.
Halozyme is a specialty pharma company focused on drug delivery and immuno-oncology with minimal direct government dependence but moderate regulatory exposure typical of biotech.
BusinessWhat HALO does
Halozyme develops proprietary drug delivery technologies (primarily hyaluronic acid-based) and manufactures biologics for partners. Revenue derives from royalties on partnered drugs, contract manufacturing services, and licensing fees. The company has limited direct Medicare/Medicaid exposure but operates in heavily regulated pharma development and manufacturing.
12 months past · 3 months futureHALO activity timeline
Lifetime Government AwardsHALO federal contracts
HALO doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding HALO
Politicians Trading HALOMembers of Congress with recent HALO positions
Congressional TradesWho in Congress is trading HALO
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills to WatchLegislation flagged by our analysis
Political ProfileWhere HALO sits in Washington
Halozyme has minimal lobbying footprint, no named legislative wins/losses, and no clear congressional alignment. Stock moves primarily on clinical/commercial biotech events, not policy.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA manufacturing compliance tightening
- drug pricing pressure from CMS
Regulatory opportunities
- Orphan drug incentives
- accelerated approval pathways for oncology
Live signals + predictions for HALO — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades HALO
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord